With the ongoing COVID-19 pandemic, virtual has become the new normal. From online lockdown quizzes to virtual events, communication through […]
Researchers have demonstrated that an in-silico approach, using virtual patient data, was able to replicate clinical trial results and investigate […]
Following the COVID-19 outbreak, which caused unprecedented disruption to the running of clinical trials, there has been an increasing interest […]
“No decision about me, without me” was to be the new standard of thinking for a more patient-centric NHS future, […]
Researchers have developed a mathematical model to simulate SARS-CoV-2 infection dynamics within hosts and the action of potential antiviral treatments. […]
Drug-induced liver injury is a common reason for the withdrawal of a drug from the market. Therefore, early assessment of […]
We summarise a recent review article, published in Archives of Biochemistry and Biophysics, that explored the key applications of AI […]
The FDA has been actively encouraging the use of real-world data (RWD) in drug development. Meanwhile, artificial intelligence (AI) methods […]
Researchers from the Institut national de la recherche Scientifique (INRS) have shown that nanoparticles can be utilised to deliver drugs […]
The cost of drug R&D has increased by ten-fold in the last 30 years, but the success rate of candidate […]
